Literature DB >> 24841982

Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.

Alona Zer1, Natasha B Leighl2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24841982     DOI: 10.1200/JCO.2013.54.4270

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis.

Authors:  Adrian D Vickers; Katherine B Winfree; Gebra Cuyun Carter; Urpo Kiiskinen; Min-Hua Jen; Donald Stull; James A Kaye; David P Carbone
Journal:  BMC Cancer       Date:  2019-04-15       Impact factor: 4.430

Review 2.  The Change in Paradigm for NSCLC Patients with EML4-ALK Translocation.

Authors:  Alessandra Bearz; Elisa De Carlo; Alessandro Del Conte; Michele Spina; Valentina Da Ros; Elisa Bertoli; Alberto Revelant; Brigida Stanzione; Umberto Tirelli
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

3.  18F-RGD PET/CT imaging reveals characteristics of angiogenesis in non-small cell lung cancer.

Authors:  Li Li; Wei Zhao; Xiaorong Sun; Ning Liu; Yue Zhou; Xiaohui Luan; Song Gao; Shuqiang Zhao; Jinming Yu; Shuanghu Yuan
Journal:  Transl Lung Cancer Res       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.